These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2512628)

  • 1. [Is hypofibrinolysis a risk factor of thrombosis?].
    Juhan-Vague I
    Rev Prat; 1989 Nov; 39(26):2337-9. PubMed ID: 2512628
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin).
    Du XH; Glas-Greenwalt P; Kant KS; Allen CM; Hayes S; Pollak VE
    Clin Nephrol; 1985 Oct; 24(4):186-91. PubMed ID: 3933871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative fibrinolytic kinetics.
    Gomez MJ; Carroll RC; Hansard RM; Goldman MH
    Curr Surg; 1987; 44(6):476-9. PubMed ID: 3123145
    [No Abstract]   [Full Text] [Related]  

  • 4. The fast inhibitor of tissue plasminogen activator in plasma during pregnancy.
    Wiman B; Csemiczky G; Marsk L; Robbe H
    Thromb Haemost; 1984 Oct; 52(2):124-6. PubMed ID: 6441300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombosis: relation to fibrinolysis].
    Sakata Y
    Nihon Naika Gakkai Zasshi; 1997 Jun; 86(6):889-96. PubMed ID: 9340353
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasminogen activator inhibitors].
    Swiatkowska M; Wilczyńska M; Cierniewski CS
    Postepy Biochem; 1991; 37(3-4):139-45. PubMed ID: 1812471
    [No Abstract]   [Full Text] [Related]  

  • 7. Endothelial-dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis.
    Francis RB; McGehee WG; Feinstein DI
    Thromb Haemost; 1988 Jun; 59(3):412-4. PubMed ID: 3142079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short-acting fibrinolysis in the etiology of venous thrombosis].
    Petäjä J; Myllylä G; Rasi V; Vahtera E
    Duodecim; 1988; 104(5):317-24. PubMed ID: 3139389
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-activator inhibitors of plasminogen].
    Juhan-Vague I; Alessi MC; Aillaud MF
    Ann Biol Clin (Paris); 1987; 45(2):202-6. PubMed ID: 3113299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemostasiology. Antifibrinolytic mechanisms of the liver].
    Jedrychowski A; Parbhoo SP; Hillenbrand P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1139-42. PubMed ID: 417485
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of the fibrinolytic system in thrombotic disease.
    Wiman B
    Acta Med Scand Suppl; 1987; 715():169-71. PubMed ID: 3109214
    [No Abstract]   [Full Text] [Related]  

  • 12. [Coagulation physiological findings in thrombosis].
    Nilsson IM; Cronberg S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(2):124-9. PubMed ID: 50976
    [No Abstract]   [Full Text] [Related]  

  • 13. [Age-related physiological changes in fibrinolysis activity and its role of pathogeneses in thrombotic disease].
    Soma M; Maeda Y; Murakami M; Kasakura S; Shimada H; Takasima H; Takada A; Takada Y
    Rinsho Ketsueki; 1987 Nov; 28(11):1922-7. PubMed ID: 3446864
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibrinolytic properties of the blood of rheumatoid arthritis patients].
    Erov NK
    Lab Delo; 1986; (7):417-20. PubMed ID: 2429032
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plasma fibrinolysis inhibitors].
    Nowak S; Nowak A
    Pol Arch Med Wewn; 1985 Feb; 73(2):113-21. PubMed ID: 2410893
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J; Rueda F
    Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract]   [Full Text] [Related]  

  • 17. [Human plasma plasminogen activator].
    Batista Diaz A
    Probl Gematol Pereliv Krovi; 1982; 27(1):40-4. PubMed ID: 6801643
    [No Abstract]   [Full Text] [Related]  

  • 18. [Endothelium, thrombosis and fibrinolysis].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1997 Dec; 47(20):2227-31. PubMed ID: 9616910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thromboembolic disease and anomalies of fibrinolysis].
    Juhan-Vague I; Aillaud MF; Valadier J; Alessi MC; Serradimigni A
    Ann Med Interne (Paris); 1986; 137(6):471-4. PubMed ID: 3101564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 plasminogen activator inhibitor and its potential influence on thrombolytic therapy.
    Loskutoff DJ
    Semin Thromb Hemost; 1988 Jan; 14(1):100-9. PubMed ID: 3127883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.